Status: Recruiting
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
A single arm clinical trial evaluating the safety and efficacy of the second generation TEVG as vascular conduits for extracardiac total cavopulmonary connection.
Participants needed: 24
Trial details
Phase: Phase 2Biological sex: AllType: InterventionalSponsor: Nationwide Children's HospitalUpdated: Jun 27, 2025Locations: 1
Eligibility criteria
Patients will be eligible for inclusion in the study if they meet all of the fol... [+2]
Patients will be excluded from participation in the study if they meet any of th... [+11]